CROI 2023
Lenacapavir’s Action May Curb HIV Infection Risk
Lenacapavir (Sunlenca, Gilead) may inhibit virion maturation by blocking the formation of HIV-capsid pentamers, ...
MAY 30, 2023
STI PEP Seeks to Mirror HIV Success
The introduction of highly active antiretroviral therapies in the late 1980s and PrEP in 2012 changed the ...
MARCH 23, 2023
HIV Outcomes During the COVID-19 Pandemic
The disruption in healthcare services caused by the COVID-19 pandemic compromised progress made toward meeting U.S. ...
FEBRUARY 27, 2023
Doxycycline PEP Does Not Prevent STIs in Cisgender Women
Doxycycline taken after sex does not prevent the sexually transmitted infections chlamydia or gonorrhea among ...
FEBRUARY 24, 2023
Investigational Combo Lenacapavir + bNAbs Would Push HIV Treatment to Twice Yearly
The investigational combination of lenacapavir with two broadly neutralizing antibodies would make twice-yearly HIV ...
FEBRUARY 23, 2023
Long-Acting Injectable ART as Effective as Daily Pills
The long-acting CAB+RPV was as effective as daily BIC/FTC/TAF in maintaining viral suppression among patients with ...
FEBRUARY 23, 2023
Dapivirine Ring Appears Safe for HIV Prevention While Breastfeeding
A monthly vaginal ring containing dapivirine to prevent HIV infection appears to be safe while breastfeeding.
FEBRUARY 22, 2023
Mpox and Severe HIV—A Toxic Relationship
Mpox should be added to the list of AIDS-defining diseases, investigators said. Those with poorly controlled HIV ...
FEBRUARY 22, 2023
The Path Forward in HIV Treatment and Vaccine Development
After the discontinuation of the phase 3 Mosaico HIV vaccine clinical trial (ClinicalTrials.gov Identifier: ...
FEBRUARY 22, 2023
Commonality of COVID-19 Rebound With Antiviral Therapy
Viral and symptom rebound of COVID-19 were not limited to patients taking antiviral therapies, such as Paxlovid.
FEBRUARY 21, 2023
LA-ART Suppresses HIV in Underserved Populations
Comprehensive support services combined with a long-acting antiretroviral treatment given every four to eight weeks ...
FEBRUARY 21, 2023
Fast-Dissolving Suppository Shows Promise for Preventing HIV Through Anal Sex
A fast-dissolving suppository being developed as an “on-demand” HIV prevention method was found to be ...
FEBRUARY 21, 2023
